在全球生物医药产业高速发展的背景下，Bio-Techne近日宣布其位于上海闵行的研发、生产和物流中心正式启用。这个重要的里程碑不仅助力提升公司在中国市场的竞争力，也昭示着中国生物医药领域的迅速崛起。 Bio-Techne是全球首家将科研试剂商品化的企业，早已在业界树立了标杆。从第一家在纳斯达克上市的生物医药公司到如今市值约120亿美元的巨头，Bio-Techne在生物技术、制药和诊断等多个领域的广 ...

The stock's fall snapped a two-day winning streak.

Bio-Techne和Waters一直积极通过合作与科学界互动。两家公司的应用科学家目前正在分析其他类别的生物分子，预计他们的发现将在未来的科学会议上展示。这项合作旨在产生更多的应用说明、网络研讨会和演示，以推广他们在生物治疗表征和开发方面的先进能力。

Bio-Techne Corporation TECH recently announced a co-marketing and co-promotion agreement with Waters Corporation. The latest ...

Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January ...

Bio-Techne (TECH) announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced ...

Techne UK’s final weekly tracker poll of the year gives Kemi Badenoch’s Tories a one point boost in the last seven days but ...

Bio-Techne Corp. TECH has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+ ...